Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing (cPMTb)

Possible genetic biomarker associated with antipsychotic-induced amenorrhea in female patients with schizophrenia (cPMTb)

Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers (cPMTb)

Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population (cPMTb)

Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy (cPMTb)

Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test (cPMTb)

Genotype-based enrichment study design for minimizing the sample size in bioequivalence study: Tolterodine and CYP2D6 genotype (cPMTb)

Pharmacodynamic effects of voglibose administered alone, administered with metformin and administered with metformin in a fixed-dose combination in healthy Korean subjects (cPMTb)

Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE) (cPMTb)

CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. (BMRC, PRCDM) 2013-International